← Leaderboards
Frank Furnari
University Of Alabama At Birmingham
$6,666,697
Attributed
$10,045,391
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,045,391 · 5
By mechanism
R01$9,508,697 · 4
R56$536,694 · 1
Top collaborators
- Adam J Engler8 shared
- Christopher Ryan Miller7 shared
- Donald M O'Rourke4 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Christopher D Willey$2,398,828
- Xiangqin Cui$800,390
- Jake Yue Chen$4,305,293
- G. Yancey Gillespie$5,456,344
- Hongju Wu$2,659,175
Others in their field
Top investigators on “Epidermal Growth Factor Receptor”
- Norman Wolmark · Nsabp Foundation, Inc.$27,726,714
- Walter John Curran · Thomas Jefferson University$26,641,549
- Robert J Coffey · Vanderbilt University$24,542,527
- Pasi A Janne · Stanford University$23,416,433
- John H Sampson · Duke University$21,673,210
- Jennifer R Grandis · University Of Pittsburgh At Pittsburgh$19,623,343
Research focus
Epidermal Growth Factor ReceptorPrimary Brain NeoplasmsMutantTumorGliomaCellsEpidermal Growth Factor Receptor ViiiPhenotypeSignal TransductionHeterogeneityGlioblastomaMutationGeneticPathway InteractionsNeoplastic CellMolecularGenetic HeterogeneityAdultProteinsGenesMediatingComplexIn VivoGene Expression
Grant awards (27)
Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM$623,787
R01 · FY2025 · NS · contact PI
Credentialing next-generation human glioma models for precision therapeutics$562,355
R01 · FY2025 · CA
Therapeutic targeting mesenchymal transition in newly diagnosed and recurrent GBM$649,226
R01 · FY2024 · NS · contact PI
Credentialing next-generation human glioma models for precision therapeutics$534,956
R01 · FY2024 · CA
Biophysical Interrogation of Signals that Drive GBM Invasion$417,510
R01 · FY2024 · NS
Credentialing next-generation human glioma models for precision therapeutics$556,011
R01 · FY2023 · CA
Genotypic Interactions in Brain Cancer Heterogeneity$536,694
R56 · FY2023 · NS · contact PI
Biophysical Interrogation of Signals that Drive GBM Invasion$467,311
R01 · FY2023 · NS
Credentialing next-generation human glioma models for precision therapeutics$131,545
R01 · FY2023 · CA
Biophysical Interrogation of Signals that Drive GBM Invasion$24,257
R01 · FY2023 · NS
Credentialing next-generation human glioma models for precision therapeutics$618,530
R01 · FY2022 · CA
Biophysical Interrogation of Signals that Drive GBM Invasion$467,311
R01 · FY2022 · NS
Genotypic Interactions in Brain Cancer Heterogeneity$345,625
R01 · FY2022 · NS · contact PI
Biophysical Interrogation of Signals that Drive GBM Invasion$61,436
R01 · FY2022 · NS
Biophysical Interrogation of Signals that Drive GBM Invasion$411,131
R01 · FY2021 · NS
Genotypic Interactions in Brain Cancer Heterogeneity$345,169
R01 · FY2021 · NS · contact PI
Biophysical Interrogation of Signals that Drive GBM Invasion$49,598
R01 · FY2021 · NS
Biophysical Interrogation of Signals that Drive GBM Invasion$425,140
R01 · FY2020 · NS
Genotypic Interactions in Brain Cancer Heterogeneity$177,502
R01 · FY2020 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$172,498
R01 · FY2020 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$350,000
R01 · FY2019 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$350,000
R01 · FY2018 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$356,344
R01 · FY2016 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$356,344
R01 · FY2015 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$352,781
R01 · FY2014 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$343,872
R01 · FY2013 · NS · contact PI
Genotypic Interactions in Brain Cancer Heterogeneity$358,458
R01 · FY2012 · NS · contact PI